- Investing Ideas
- /
- French Undervalued Stocks Based On Cash Flows
French Undervalued Stocks Based On Cash Flows
UPDATED May 16, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
57 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ALACT | €0.98 | 29.9% | -84.0% | €12.9m | €1.00 | PB35x | E81.5% | n/a | Pharmaceuticals & Biotech | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | Pharmaceuticals & Biotech | ||
ALECO | €3.14 | -0.3% | -49.8% | €10.6m | €4.50 | PB2.1x | E103.5% | n/a | Consumer Retailing | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | Pharmaceuticals & Biotech | ||
ALKLK | €0.72 | -13.1% | -22.7% | €5.3m | €1.10 | PB0.7x | E115.0% | n/a | Tech | ||
ALLPL | €0.95 | 0% | -66.5% | €11.5m | €2.00 | PB3.3x | E97.3% | n/a | Consumer Services | ||
ALCOR | €35.10 | 0% | 150.7% | €154.5m | €35.00 | PS12.1x | E136.3% | n/a | Healthcare | ||
ALHGR | €11.40 | -1.7% | 14.5% | €166.8m | €15.83 | PS27.6x | E99.2% | n/a | Materials | ||
ALLOG | €1.15 | -8.4% | 212.0% | €10.4m | €1.85 | PE16.5x | E30.5% | n/a | Tech | ||
GNFT | €3.47 | 2.8% | -10.2% | €172.3m | €9.38 | PS5x | E54.7% | n/a | Pharmaceuticals & Biotech | ||
ALISP | €3.18 | 0.6% | -20.9% | €46.8m | €7.90 | PE16.1x | E48.0% | 0% | Media | ||
AL2SI | €4.46 | 1.9% | 174.5% | €84.8m | €8.25 | PB3.1x | E104.3% | n/a | Tech | ||
CGG | €0.56 | 22.7% | -17.8% | €399.6m | n/a | PE33.4x | E50.4% | n/a | Energy | ||
CLA | €2.31 | -2.3% | 17.0% | €130.8m | €4.75 | PE-26.2x | E90.3% | n/a | Software | ||
ALBIZ | €6.00 | 0.7% | 2.7% | €35.0m | €10.67 | PE277.3x | E59.7% | n/a | Media | ||
ALAIR | €4.62 | 1.3% | -36.3% | €28.0m | €6.50 | PE19.5x | E32.6% | n/a | Consumer Durables | ||
IPH | €2.34 | 2.6% | -14.4% | €189.2m | €6.27 | PS3.1x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
ALPCV | €1.89 | 0.5% | -34.1% | €8.5m | €3.60 | PE74.5x | E98.5% | n/a | Capital Goods | ||
ALMND | €0.89 | 0% | -49.7% | €63.0m | n/a | PB3.7x | E119.1% | 0% | Consumer Durables | ||
ALPAT | €15.20 | 12.6% | 12.6% | €16.5m | €11.50 | PS7.1x | E92.7% | n/a | Pharmaceuticals & Biotech | ||
MLBMD | €8.00 | 0% | n/a | €29.2m | €14.00 | PS26x | E106.7% | n/a | Software | ||
MEDCL | €13.70 | -11.0% | 108.8% | €393.9m | €19.24 | PS27.9x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
ALICA | €9.94 | 1.2% | -41.2% | €80.4m | €16.00 | PE14.7x | E26.1% | 2.0% | Tech | ||
ALFRE | €3.32 | -0.3% | -40.8% | €186.4m | €5.30 | PE12.9x | E22.7% | 2.4% | Commercial Services |